Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 585, 492-493 (2020)
doi: https://doi.org/10.1038/d41586-020-02684-9
Updates & Corrections
-
Clarification 18 September 2020: The chart describing the National Academies of Sciences, Engineering and Medicine's vaccine allocation plan was updated to make clear that phases 1 and 2 could occur simultaneously.
References
Williams, J. H. & Dawson, A. BMC Med. Ethics 21, 40 (2020).
Scientists relieved as coronavirus vaccine trial restarts — but question lack of transparency
The unequal scramble for coronavirus vaccines — by the numbers
Researchers highlight ‘questionable’ data in Russian coronavirus vaccine trial results
The underdog coronavirus vaccines that the world will need if front runners stumble
India will supply coronavirus vaccines to the world — will its people benefit?